<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00231127</url>
  </required_header>
  <id_info>
    <org_study_id>M05-1522</org_study_id>
    <nct_id>NCT00231127</nct_id>
  </id_info>
  <brief_title>Osteoporosis and Chronic Obstructive Pulmonary Disease (COPD)</brief_title>
  <official_title>Osteoporosis and COPD (Making of a Database)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catharina Ziekenhuis Eindhoven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goals of the trial are:&#xD;
&#xD;
        -  To determine the prevalence of osteoporosis in subgroups of COPD patients.&#xD;
&#xD;
        -  To look for risk factors of osteoporosis in COPD patients.&#xD;
&#xD;
        -  To create sub-groups for prospective research concerning the effects of bisphosphonates&#xD;
           on osteoporosis variables in COPD patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      Osteoporosis is defined as a systemically skeletal disorder characterized by a low bone mass&#xD;
      and deterioration of the micro-architecture of the bone and is therefore associated with a&#xD;
      higher risk of fractures. Large epidemiological studies to determine the incidence and&#xD;
      prevalence of osteoporosis in COPD patients in different stages of their disease are not&#xD;
      available. The etiology of osteoporosis in COPD patients is complex and depends on multiple&#xD;
      factors.&#xD;
&#xD;
      Goals of the Trial:&#xD;
&#xD;
        -  To determine the prevalence of osteoporosis in subgroups of COPD patients.&#xD;
&#xD;
        -  To look for risk factors of osteoporosis in COPD patients.&#xD;
&#xD;
        -  To create sub-groups for prospective research concerning the effects of bisphosphonates&#xD;
           on osteoporosis variables in COPD patients.&#xD;
&#xD;
      Study Design:&#xD;
&#xD;
      Patients diagnosed with COPD (according to the American Thoracic Society [ATS] guidelines and&#xD;
      divided in stages according to the Global Initiative on Obstructive Lung Diseases&#xD;
      [GOLD]-classification) who visit the out-patient clinic of pulmonology of the Catharina&#xD;
      Hospital Eindhoven will be asked to participate in the trial. A database will be created&#xD;
      (prospectively) of the (medical) information about these patients, which will be analysed&#xD;
      retrospective. To gather information we will use the medical records, a questionnaire, a&#xD;
      blood sample, long function testing including a 6-minute walking test and a DEXA-scan.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">250</enrollment>
  <condition>COPD</condition>
  <condition>Osteoporosis</condition>
  <condition>Osteopenia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic Obstructive Pulmonary Disease Patients visiting the pulmonary outpatient clinic of&#xD;
        the Catharina Hospital Eindhoven.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Men and women&#xD;
&#xD;
          -  COPD according to the ATS-guidelines, divided in severity according to the GOLD&#xD;
             criteria&#xD;
&#xD;
          -  Written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  No written consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lidwien Graat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catharina Hospital Eindhoven (Department of Pulmonology)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Catharina Hospital Eindhoven</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord-Brabant</state>
        <zip>5602 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>October 3, 2005</study_first_submitted>
  <study_first_submitted_qc>October 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2005</study_first_posted>
  <last_update_submitted>November 9, 2009</last_update_submitted>
  <last_update_submitted_qc>November 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>Lidwien Graat-Verboom/MD (principal investigator)</name_title>
    <organization>Catharina Hospital Eindhoven</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>Osteopenia</keyword>
  <keyword>Glucocorticoids</keyword>
  <keyword>GOLD</keyword>
  <keyword>BODE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

